400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
2021-10-21
基因药物研发商
医药研发/制造
化学&生物药
辉瑞;
辉瑞;
Vida Ventures;
Vida Ventures;
Tekla Capital Management;
奥博资本;
MPM Capital;
EcoR1 Capital;
Superstring Capital;
Osage University Partners;
NS Investment;
Colt Ventures;
赛诺菲
2021-08-18
肿瘤治疗药物研发商
医药研发/制造
化学&生物药
Alexandria Venture Investments;
Alexandria Venture Investments;
M Ventures;
M Ventures;
Mirae Asset Capital;
Ono Venture Investment, Inc.;
Solasta Ventures;
American Cancer Society BrightEdge;
Agent Capital;
NS Investment;
Longwood Fund;
The Mark Foundation for Cancer Research;
Leaps by Bayer;
诺华;
Evotec
2021-08-04
自身免疫和炎症疾病细胞疗法开发商
医药研发/制造
化学&生物药
Casdin Capital;
Casdin Capital;
JDRF T1D Fund;
JDRF T1D Fund;
8VC;
ARCH Venture Partners;
Janus Henderson Investors;
Vertex Ventures;
Osage University Partners;
Frazier Management;
Avidity Partners;
NS Investment;
ArrowMark Partners;
八方资本;
Alexandria Venture Investments;
GV;
Deep Track Capital;
Mirae Asset Capital;
LifeForce Capital;
汇桥资本;
富达国际
2020-03-11
抗体偶联药物研发商
医药研发/制造
化学&生物药
Pontifax;
Pontifax;
NS Investment;
NS Investment;
Colt Ventures;
Nextech Invest;
U.S. Venture Partners
2019-03-15
靶向再生抗体研发商
医药研发/制造
化学&生物药
Horizons Ventures;
Horizons Ventures;
NS Investment;
NS Investment;
The Column Group;
Hartford HealthCare Endowment
2018-11-13
一家致力于开发治疗癌症的下一代免疫药物和其他疾病的私人控股生物制药公司
医药研发/制造
化学&生物药
泉创资本;
泉创资本;
奥博资本;
奥博资本;
辉瑞;
Taiho Ventures;
高瓴资本;
NS Investment;
Surveyor Capital;
Sofinnova Partners
2018-09-05
基因调控药物开发商
医药研发/制造
化学&生物药
Section 32;
Section 32;
Casdin Capital;
Casdin Capital;
赛诺菲;
NS Investment;
富达国际;
Foresite Capital;
SVB Leerink
中国农药工业协会2026-01-26
经纬创投2026-01-26
GMP办公室2026-01-26
功能与专用化学品2026-01-26
一度医药2026-01-26
细胞与基因治疗领域2026-01-26
同写意2026-01-26
CIO合规保证组织2026-01-26
德联资本2026-01-26
生物安全情报网2026-01-26